The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
America must win the AI race — and prepare for the worst

Related Posts

Tech 5: US Government Strikes Big Tech Deal,...

August 17, 2025

HITIQ Shifts to Consumer Market with VAFA Partnership

March 24, 2025

VVC Provides Further Update on the Helium Project...

December 13, 2023

Top 5 Most-popular Uranium Stories of 2024

December 28, 2024

Silver Price at New Base, What Comes Next?...

July 15, 2025

Charbone Hydrogen Announces Q1 2025 Financial Results

May 31, 2025

Galan Investor Presentation Singapore March 2024

April 2, 2024

Canadian Investment Regulatory Organization Trade Resumption – OM

November 15, 2024

Newmont to Sell Cripple Creek & Victor Mine...

December 11, 2024

+30,000m Drilling Program to Commence Across Brightstar’s Enlarged...

May 6, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,550)
    • Investing (4,188)
    • Politics (5,558)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved